Maximize Your Productivity at the CAPTURE Step with Affinity Resins


At the capture phase of purification, the primary goals are to isolate the target molecule as quickly as possible from the clarified feedstock, reduce the process volume to a manageable scale for subsequent steps, and maximize yield and economy.

Affinity chromatography, a method of separating biochemical mixtures based on a highly specific interaction, can effectively achieve these goals.

Merck’s range of affinity resins is designed for cost effective, high throughput purification of monoclonal, polyclonal and engineered antibodies and are especially suited for large-scale purification of today’s higher titer therapeutic antibodies.
Affinity Chromatography Resins from Merck
NEW!

Affinity Resins for Affinity chromatographyEshmuno® P anti-A and Eshmuno® P anti-B resins

High performance, acid and alkaline resistant affinity chromatography media designed for the removal of anti-A and anti-B isoagglutinin antibodies from plasma-derived Immunoglobulin (Ig) therapeutics.

Learn More
 
 
Eshmuno® CP-FT Resin

Eshmuno® CP-FT Resin
First cation exchange resin specifically developed for the flow-through
removal of mAb aggregates

Learn More
High productivity membrane chromatography: Enabling the next generation bioprocessing paradigm

On-Demand Webinar
High productivity membrane chromatography: Enabling the next generation bioprocessing paradigm

Watch Now
Advancing Next Generation Bioprocessing

 

ChromaTalk: the process-scale chromatography community on LinkedIn

ChromaTALK™
the chromatography community on LinkedIn®

Join Now